PDS Biotechnology Corpora...

NASDAQ: PDSB · Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT

PDS Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
59.07K 59.07K 59.07K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
59.79K 74.92K 74.2K 59.07K 58.34K 117.88K 177.84K 175.01K 160.61K 146.2K 132.18K 181.81K 243.34K 183.08K 122.74K 61.53K n/a n/a
Gross Profit
-727 -15.86K -15.13K -59.07K -58.34K -117.88K -177.84K -175.01K -258.28K -243.88K -229.85K -279.48K -243.34K -244.61K -246.39K -185.18K -123.65K -62.12K
Operating Income
-34.27M -35.33M -36.32M -39.37M -39.71M -43.72M -43.05M -51.46M -48.22M -42.62M -41.67M -29.17M -28.86M -26.87M -21.44M -19.14M -16.09M -13.92M
Interest Income
1.88M 2.22M 2.51M 2.69M 2.77M 2.84M 2.9M 3.07M 2.34M 1.66M 935.33K 82.12K 83.33K 9.39K 4.35K 3.38K 3.23K 9.24K
Pretax Income
-37.77M -37.53M -38.48M -41.42M -41.55M -45.29M -44.35M -52.59M -49.16M -43.24M -42.05M -29.24M -28.77M -26.86M -21.43M -19.14M -16.09M -13.91M
Net Income
-36.6M -35.5M -37.61M -40.56M -40.68M -43.88M -42.94M -51.18M -47.76M -42.04M -40.85M -28.04M -27.57M -22.34M -16.92M -14.63M -11.57M -13.91M
Selling & General & Admin
12.89M 13.64M 13.74M 13.84M 14.53M 15.07M 15.27M 15.01M 13.86M 12.5M 12.24M 12.51M 12.86M 11.87M 10.18M 8.79M 7.36M 6.54M
Research & Development
21.38M 21.69M 22.57M 25.5M 25.15M 28.62M 27.76M 36.45M 34.36M 30.11M 29.43M 16.67M 16M 15M 11.25M 10.34M 8.72M 7.37M
Other Expenses
-16K -17K -17K -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
34.25M 35.31M 36.29M 39.34M 39.68M 43.69M 43.03M 51.46M 48.22M 42.62M 41.67M 29.17M 28.86M 26.87M 21.44M 19.14M 16.09M 13.92M
Interest Expense
1.1M 4.43M 4.67M 4.75M 4.61M 4.41M 4.21M 4.28M 3.36M 2.36M 1.4M 145.25K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -14.4K -28.81K -28.81K -28.81K -14.4K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
26.65M 35.33M 36.32M 39.37M 39.71M 43.72M 43.05M 51.46M 48.22M 42.62M 41.67M 29.17M 28.86M 26.87M 21.44M 19.14M 16.09M 13.92M
Income Tax Expense
-1.17M -2.04M -869K -869K -873.73K -1.41M -1.41M -214.89K -210.16K -3.15K -5.7K -1.2M -1.26M -4.58M -4.58M -4.58M -4.48M 42.59K
Shares Outstanding (Basic)
45.9M 40.52M 36.45M 36.81M 36.69M 34.82M 31.67M 30.91M 30.8M 30.43M 28.77M 28.46M 28.45M 26.16M 28.43M 28.43M 23.16M 22.26M
Shares Outstanding (Diluted)
45.9M 40.52M 36.45M 36.81M 36.69M 34.82M 31.67M 30.91M 30.8M 30.43M 28.77M 28.46M 28.45M 26.16M 28.43M 28.43M 23.16M 22.26M
EPS (Basic)
-0.93 -0.95 -1.04 -1.16 -1.22 -1.36 -1.38 -1.79 -1.7 -1.53 -1.53 -1 -0.98 -0.81 -0.63 -0.67 -0.64 -0.8
EPS (Diluted)
-0.93 -0.95 -1.04 -1.16 -1.22 -1.36 -1.38 -1.79 -1.7 -1.53 -1.53 -1 -0.98 -0.81 -0.63 -0.67 -0.64 -0.8
EBITDA
-32.68M -33.05M -33.75M -36.61M -36.88M -40.76M -39.97M -49.07M -46.48M -41.63M -41.42M -28.93M -28.71M -26.8M -21.43M -19.14M -16.08M -13.91M
EBIT
-25.1M -33.11M -33.81M -36.67M -36.94M -40.88M -40.14M -48.3M -45.55M -40.62M -40.4M -28.84M -28.78M -26.86M -21.44M -19.14M -16.09M -13.92M
Depreciation & Amortization
35.72K 50.84K 59.79K 59.07K 58.34K 117.88K 177.84K 175.01K 258.28K 243.88K 229.85K 219.23K 122.82K 63.84K 5.36K 8.31K 76.08K 78.72K